The use of pegylated interferon a-2a in a cohort of Greek patients with mycosis fungoides

J Eur Acad Dermatol Venereol. 2022 Apr;36(4):e291-e293. doi: 10.1111/jdv.17795. Epub 2021 Nov 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Greece
  • Humans
  • Interferon-alpha* / therapeutic use
  • Mycosis Fungoides* / drug therapy
  • Polyethylene Glycols* / therapeutic use
  • Recombinant Proteins / therapeutic use
  • Skin Neoplasms* / drug therapy

Substances

  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2a